Diacylglycerol kinases (Dgk) phosphorylate diacylglycerol (DG) to phosphatidic acid (PA), thus turning off and on, respectively, DG-mediated and PA-mediated signaling pathways. We previously showed that hepatocyte growth factor (HGF), vascular endothelial growth factor, and anaplastic lymphoma kinase activate Dgk in endothelial and leukemia cells through a Src-mediated mechanism and that activation of Dgk is required for chemotactic, proliferative, and angiogenic signaling in vitro. Here, we investigate the downstream events and signaling pathways regulated by Dgk, leading to cell scatter and migration upon HGF treatment and v-Src expression in epithelial cells. We report that specific inhibition of Dgk, obtained either pharmacologically by R59949 treatment, or by expression of Dgkdominant-negative mutant, or by small interfering RNA-mediated down-regulation of endogenous Dgk, impairs 1) HGF- and v-Src-induced cell scatter and migration, without affecting the loss of intercellular adhesions; 2) HGF-induced cell spreading, lamellipodia formation, membrane ruffling, and focal adhesions remodeling; and 3) HGF-induced Rac activation and membrane targeting. In summary, we provide evidence that Dgk, activated downstream of tyrosine kinase receptors and Src, regulates crucial steps directing Rac activation and Rac-dependent remodeling of actin cytoskeleton and focal contacts in migrating epithelial cells.

Diacylglycerol Kinase-{alpha} Mediates HGF-induced Epithelial Cell Scatter by Regulating Rac Activation and Membrane Ruffling.

CUTRUPI, SANTINA;PORPORATO, Paolo Ettore;SANTORO, Massimo Mattia;GRAZIANI A.
2007-01-01

Abstract

Diacylglycerol kinases (Dgk) phosphorylate diacylglycerol (DG) to phosphatidic acid (PA), thus turning off and on, respectively, DG-mediated and PA-mediated signaling pathways. We previously showed that hepatocyte growth factor (HGF), vascular endothelial growth factor, and anaplastic lymphoma kinase activate Dgk in endothelial and leukemia cells through a Src-mediated mechanism and that activation of Dgk is required for chemotactic, proliferative, and angiogenic signaling in vitro. Here, we investigate the downstream events and signaling pathways regulated by Dgk, leading to cell scatter and migration upon HGF treatment and v-Src expression in epithelial cells. We report that specific inhibition of Dgk, obtained either pharmacologically by R59949 treatment, or by expression of Dgkdominant-negative mutant, or by small interfering RNA-mediated down-regulation of endogenous Dgk, impairs 1) HGF- and v-Src-induced cell scatter and migration, without affecting the loss of intercellular adhesions; 2) HGF-induced cell spreading, lamellipodia formation, membrane ruffling, and focal adhesions remodeling; and 3) HGF-induced Rac activation and membrane targeting. In summary, we provide evidence that Dgk, activated downstream of tyrosine kinase receptors and Src, regulates crucial steps directing Rac activation and Rac-dependent remodeling of actin cytoskeleton and focal contacts in migrating epithelial cells.
2007
18(12)
4859
4871
cell migration; Met; lipid signalling
CHIANALE F; S. CUTRUPI; RAINERO E; BALDANZI G; PORPORATO PE; TRAINI S; FILIGHEDDU N; GNOCCHI VF; SANTORO MM; PAROLINI O; VAN BLITTERSWIJK WJ; SINIGAGLIA; F; GRAZIANI A
File in questo prodotto:
File Dimensione Formato  
Chianale et al 07.pdf

Accesso riservato

Dimensione 1.74 MB
Formato Unknown
1.74 MB Unknown   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/21544
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 29
social impact